Management of adverse events associated with tyrosine kinase inhibitors in chronic myeloid leukemia
Crossref DOI link: https://doi.org/10.1007/s00277-015-2318-y
Published Online: 2015-03-27
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rea, Delphine
Text and Data Mining valid from 2015-03-27